Prior Auth Required
0176U - Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / ServiceCytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)
Procedure / Service Description
Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic - 0174U benefit of 39 chemotherapy and targeted therapeutic oncology agents 0175U Psychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genes 0176U Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA) Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported as PIK3CA
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.